|
Thursday, August 11, 2005
Anadys Pharmaceuticals Raises $71.3M in IPO
San Diego-based Anadys Pharmaceuticals, a biotechnology firm developing medicines for treating viral and bacterial infections, has raised $71.3M in an IPO on the NASDAQ. The firm offered 5,750,000 shares of its stock at $12.40 per share. The IPO was managed by Credit Suisse First Boston, SG Cowen & Co., Piper Jaffray, and Needham & Company. The firm is backed by Coastview Capital, HBM Partners, Lotus BioScience, and Venrock Associates.
posted on Thursday, August 11, 2005
|
 RSS
 Email
Twitter
Previous news:
Tuesday, January 6, 2009
Monday, January 5, 2009
Friday, January 2, 2009
Wednesday, December 31, 2008
Tuesday, December 30, 2008
|
